세계의 피부과용 영상 기기 시장 규모, 점유율 및 동향 분석 보고서 : 모달리티별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Dermatology Imaging Devices Market Size, Share & Trends Analysis Report By Modality (Digital Photographic Imaging, OCT, Dermatoscope, High Frequency Ultrasound), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,194,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,571,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,325,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

피부과용 영상 기기 시장 성장 및 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면, 피부과용 영상 기기 세계 시장 규모는 2030년까지 56억 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 연평균 13.09%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

암 및 염증성 피부질환과 같은 피부질환의 유병률 증가가 시장 성장의 주요 요인입니다. 예를 들어, 국제 암 연구 기관에 따르면 2022년에는 전 세계적으로 331,722건의 흑색종 암이 보고될 것이며, 2027년에는 1,262,756건에 달할 것으로 추정됩니다. 또한, 기술 발전도 시장 성장을 가속할 것으로 예상됩니다.

피부과용 영상 기기는 피부 병변 및 기타 관련 증상을 비침습적이고 고해상도로 시각화할 수 있어 효율적입니다. 다양한 피부 질환의 형태, 구조, 특징에 대한 상세한 정보를 제공하여 피부과 전문의가 정확한 진단과 치료 전략을 수립할 수 있도록 돕습니다. 또한, 원격 진료를 가능하게 하고, 전문의들이 이미지와 전문 지식을 교환할 수 있도록 하여 환자 치료를 개선합니다.

고해상도 이미지, AI와의 통합, 3D 이미징 등 피부과용 영상 기기의 기술 발전은 시장 성장에 더욱 기여할 것으로 예상됩니다. 예를 들어, 2023년 6월, 피부과용 의료용 이미징 시스템 제조업체인 FotoFinder Systems GmbH는 최근 미용용 휴대용 이미징 솔루션인 미즈마(meesma)와 전신 피부경 검사를 위한 AI 어시스턴트인 AIMEE라는 AI 어시스턴트가 탑재된 4세대 FotoFinder ATBM master를 발표했습니다. 이 최첨단 시스템은 2023년 7월 3일부터 8일까지 싱가포르에서 열리는 제25회 세계피부과학회(WCD)에서 처음으로 전문가들에게 공개될 예정입니다.

시장 진출기업들은 경쟁력을 유지하고 시장 점유율을 확대하기 위해 다양한 전략적 노력을 기울이고 있습니다. 2023년 5월, Orlucent의 피부 형광 이미징 시스템은 미국 식품의약국(FDA)으로부터 혁신적 의료기기 지정(Breakthrough Device Designation, BDD)을 획득했습니다. 이 혁신적인 도구는 침습적 시술 없이도 성인의 비정상적인 두더지 발생과 관련된 생물학적 조직 변형 활동을 식별하고 평가할 수 있습니다.

피부과용 영상 기기 시장 보고서 - 주요 내용

• 모달리티별로 보면, 2023년 Dermoscope 부문이 41.42%의 가장 큰 매출 점유율로 시장을 주도할 것으로 예상되며, 디지털 사진 이미징 부문은 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
• 용도별로는 피부암 부문이 2023년 48.63%의 가장 큰 매출 점유율로 시장을 차지했습니다. 반면, 성형 및 재건 수술 부문은 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
• 최종 용도별로는 병원이 2023년 43.99%의 가장 큰 매출 점유율로 시장을 차지했습니다. 또한 피부과 센터 부문은 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
• 북미는 2023년 39.48%의 매출 점유율로 시장을 장악했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 피부과용 영상 기기 시장 : 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 시장 기회 분석
• 피부과용 영상 기기 시장 분석 툴
  • 업계 분석 - Porter의 Five Forces 분석
  • PESTEL 분석

제4장 피부과용 영상 기기 시장 : 모달리티 추정·동향 분석

• 모달리티 시장 점유율, 2023년 & 2030년
• 부문 대시보드
• 모달리티별 세계의 피부과용 영상 기기 시장 전망
• 시장 규모, 예측 및 동향 분석, 2018-2030년
• 디지털 사진 이미징
• OCT
• 피부경
• 고주파 초음파
• 기타

제5장 피부과용 영상 기기 시장 : 용도 추정·동향 분석

• 용도 시장 점유율, 2023년 & 2030년
• 부문 대시보드
• 용도별 세계의 피부과용 영상 기기 시장 전망
• 시장 규모, 예측 및 동향 분석, 2018-2030년
• 피부암
• 염증성 피부염
• 성형 수술 및 재건 수술
• 기타

제6장 피부과용 영상 기기 시장 : 최종 용도 추정·동향 분석

• 최종 용도 시장 점유율, 2023년 및 2030년
• 부문 대시보드
• 최종 용도별 세계의 피부과용 영상 기기 시장 전망
• 시장 규모, 예측 및 동향 분석, 2018-2030년
• 병원
• 피부과 센터
• 전문 클리닉

제7장 피부과용 영상 기기 시장 : 지역 추정·동향 분석, 국가별, 모달리티별, 용도별, 최종 용도별

• 지역 시장 대시보드
• 세계의 지역 시장 현황
• 시장 규모와 예측 동향 분석, 2018-2030년
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제8장 경쟁 구도

• 주요 시장 진출기업의 최근 동향과 영향 분석
• 예측 기간 동안 연평균 복합 성장률(CAGR)
• 주요 기업의 시장 점유율 분석, 2023년
• 기업 포지션 분석, 2023년
• 기업 분류(신규 기업, 혁신 기업, 리더)
• 기업 개요
  • Canfield Scientific, Inc.
  • FotoFinder Systems GmbH
  • e-con Systems Inc.
  • Courage+Khazaka electronic GmbH
  • Longport, Inc.
  • Cortex Technology
  • DRAMINSKI SA
  • GE HealthCare
  • VisualSonics
  • Clarius
  • Koninklijke Philips NV
  • Michelson Diagnostics Ltd(MDL)
  • Caliber Imaging and Diagnosis
  • DermLite

LSH

영문 목차

영문목차

Dermatology Imagine Devices Market Growth & Trends:

The global dermatology imaging devices market size is anticipated to reach USD 5.60 billion by 2030 and it is projected to grow at a CAGR of 13.09% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of skin disorders such as cancer, and inflammatory dermatoses, among others are the major contributing factors for market growth. For instance, according to the International Agency for Research on Cancer, in 2022, globally 331, 722 cases of melanoma cancer were reported, the cases are further estimated to reach 1,262,756 by 2027. Furthermore, technological advancements are also expected to propel market growth.

Dermatology imaging devices are efficient as they provide non-invasive, high-resolution visualization of skin lesions and other related conditions. They help dermatologists by providing detailed morphology, structure, and traits of diverse skin abnormalities, which thereby help in precise diagnosis and treatment strategizing. Moreover, they enable remote consultation, assist specialists to exchange images and expertise, thereby enhancing patient care.

Technological advancements in dermatology imaging devices such as high-resolution images, integration with AI, 3D imaging are further expected to contribute to the market growth. For instance, ,in June 2023, FotoFinder Systems GmbH, a prominent manufacturer of medical imaging systems for dermatology, has recently unveiled two new cutting-edge innovations - the meesma, a portable imaging solution for aesthetics, and the fourth generation FotoFinder ATBM master equipped with an AI assistant called AIMEE for Total Body Dermoscopy. These state-of-the-art systems are showcased for the first time to experts at the "25th World Congress of Dermatology" (WCD) in Singapore, scheduled from 3rd to 8th July 2023.

Market participants are implementing a range of strategic initiatives to maintain competitiveness and expand their market share. These initiatives include product launch, government approval, expansion, partnership, merger, and acquisitions. In May 2023,Orlucent's skin fluorescence imaging system has been granted Breakthrough Device Designation (BDD) by the US Food and Drug Administration (FDA).t's a handheld point-of-care device that provides molecular-level imaging and analysis of moles. This innovative tool can identify and assess biological tissue-remodeling activity associated with the development of abnormal moles in adults, all without requiring invasive procedures.

Dermatology Imaging Devices Market Report Highlights:

• Based on modality, the dermatoscope segment led the market with the largest revenue share of 41.42% in 2023, Also, the digital photographic imaging segment is anticipated to grow at the fastest CAGR during the forecast period
• Based on application, the skin cancer segment held the market with the largest revenue share of 48.63% in 2023. On other hand, the plastic and reconstructive surgery segment is expected to grow at the fastest CAGR during the forecast period
• Based on end-use, the hospitals held the market with the largest revenue share of 43.99% in 2023. And, the dermatology centers segment is expected to grow at a fastest CAGR over the forecast period.
• North America dominated the market with the revenue share of 39.48% in 2023.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Modality
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Dermatology Imaging Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of skin disorders and skin cancers
    • 3.2.1.2. Growing awareness for the early disease diagnosis
    • 3.2.1.3. Rising demand for non-invasive diagnostic procedures
    • 3.2.1.4. Technological advancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of awareness about the benefits of dermatology imaging
    • 3.2.2.2. High cost of dermatology imaging devices
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Increasing demand for portable and handheld imaging devices
    • 3.2.3.2. Growing healthcare expenditure in emerging economies
• 3.3. Dermatology Imaging Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Dermatology Imaging Devices Market: Modality Estimates & Trend Analysis

• 4.1. Modality Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Dermatology Imaging Devices Market by Modality Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Digital Photographic Imaging
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Optical Coherence Tomography (OCT)
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Dermatoscope
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. High Frequency Ultrasound
  • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Dermatology Imaging Devices Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Dermatology Imaging Devices Market by Application Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Skin Cancers
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Inflammatory Dermatoses
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.2. Skin psoriasis
    • 5.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.3. Eczema (Atopic dermatitis)
    • 5.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.4. Others
    • 5.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Plastic and Reconstructive Surgery
  • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Dermatology Imaging Devices Market: End Use Estimates & Trend Analysis

• 6.1. End Use Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Dermatology Imaging Devices Market by End Use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Dermatology Centers
  • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Specialty Clinics
  • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Dermatology Imaging Devices Market: Regional Estimates & Trend Analysis by Country, Modality, Application, and End Use

• 7.1. Regional Market Dashboard
• 7.2. Global Regional Market Snapshot
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework
    • 7.4.1.3. Reimbursement structure
    • 7.4.1.4. Competitive scenario
    • 7.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Reimbursement structure
    • 7.4.2.4. Competitive scenario
    • 7.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. UK
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Reimbursement structure
    • 7.5.1.4. Competitive scenario
    • 7.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Reimbursement structure
    • 7.5.2.4. Competitive scenario
    • 7.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. France
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Reimbursement structure
    • 7.5.3.4. Competitive scenario
    • 7.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Italy
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Reimbursement structure
    • 7.5.4.4. Competitive scenario
    • 7.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Spain
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Reimbursement structure
    • 7.5.5.4. Competitive scenario
    • 7.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Norway
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Reimbursement structure
    • 7.5.6.4. Competitive scenario
    • 7.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Reimbursement structure
    • 7.5.7.4. Competitive scenario
    • 7.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Reimbursement structure
    • 7.5.8.4. Competitive scenario
    • 7.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Reimbursement structure
    • 7.6.1.4. Competitive scenario
    • 7.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Reimbursement structure
    • 7.6.2.4. Competitive scenario
    • 7.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Reimbursement structure
    • 7.6.3.4. Competitive scenario
    • 7.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Australia
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Reimbursement structure
    • 7.6.4.4. Competitive scenario
    • 7.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Reimbursement structure
    • 7.6.5.4. Competitive scenario
    • 7.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Reimbursement structure
    • 7.6.6.4. Competitive scenario
    • 7.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Reimbursement structure
    • 7.7.1.4. Competitive scenario
    • 7.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Mexico
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Reimbursement structure
    • 7.7.2.4. Competitive scenario
    • 7.7.2.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Reimbursement structure
    • 7.7.3.4. Competitive scenario
    • 7.7.3.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework
    • 7.8.1.3. Reimbursement structure
    • 7.8.1.4. Competitive scenario
    • 7.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Reimbursement structure
    • 7.8.2.4. Competitive scenario
    • 7.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Reimbursement structure
    • 7.8.3.4. Competitive scenario
    • 7.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Reimbursement structure
    • 7.8.4.4. Competitive scenario
    • 7.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key Company Market Share Analysis, 2023
• 8.4. Company Position Analysis, 2023
• 8.5. Company Categorization (Emerging Players, Innovators, and Leaders)
• 8.6. Company Profiles
  • 8.6.1. Canfield Scientific, Inc.
    • 8.6.1.1. Company overview
    • 8.6.1.2. Financial performance
    • 8.6.1.3. Product benchmarking
    • 8.6.1.4. Strategic initiatives
  • 8.6.2. FotoFinder Systems GmbH
    • 8.6.2.1. Company overview
    • 8.6.2.2. Financial performance
    • 8.6.2.3. Product benchmarking
    • 8.6.2.4. Strategic initiatives
  • 8.6.3. e-con Systems Inc.
    • 8.6.3.1. Company overview
    • 8.6.3.2. Financial performance
    • 8.6.3.3. Product benchmarking
    • 8.6.3.4. Strategic initiatives
  • 8.6.4. Courage+Khazaka electronic GmbH
    • 8.6.4.1. Company overview
    • 8.6.4.2. Financial performance
    • 8.6.4.3. Product benchmarking
    • 8.6.4.4. Strategic initiatives
  • 8.6.5. Longport, Inc.
    • 8.6.5.1. Company overview
    • 8.6.5.2. Financial performance
    • 8.6.5.3. Product benchmarking
    • 8.6.5.4. Strategic initiatives
  • 8.6.6. Cortex Technology
    • 8.6.6.1. Company overview
    • 8.6.6.2. Financial performance
    • 8.6.6.3. Product benchmarking
    • 8.6.6.4. Strategic initiatives
  • 8.6.7. DRAMINSKI S. A.
    • 8.6.7.1. Company overview
    • 8.6.7.2. Financial performance
    • 8.6.7.3. Product benchmarking
    • 8.6.7.4. Strategic initiatives
  • 8.6.8. GE HealthCare
    • 8.6.8.1. Company overview
    • 8.6.8.2. Financial performance
    • 8.6.8.3. Product benchmarking
    • 8.6.8.4. Strategic initiatives
  • 8.6.9. VisualSonics
    • 8.6.9.1. Company overview
    • 8.6.9.2. Financial performance
    • 8.6.9.3. Product benchmarking
    • 8.6.9.4. Strategic initiatives
  • 8.6.10. Clarius
    • 8.6.10.1. Company overview
    • 8.6.10.2. Financial performance
    • 8.6.10.3. Product benchmarking
    • 8.6.10.4. Strategic initiatives
  • 8.6.11. Koninklijke Philips N.V.
    • 8.6.11.1. Company overview
    • 8.6.11.2. Financial performance
    • 8.6.11.3. Product benchmarking
    • 8.6.11.4. Strategic initiatives
  • 8.6.12. Michelson Diagnostics Ltd (MDL)
    • 8.6.12.1. Company overview
    • 8.6.12.2. Financial performance
    • 8.6.12.3. Product benchmarking
    • 8.6.12.4. Strategic initiatives
  • 8.6.13. Caliber Imaging and Diagnosis
    • 8.6.13.1. Company overview
    • 8.6.13.2. Financial performance
    • 8.6.13.3. Product benchmarking
    • 8.6.13.4. Strategic initiatives
  • 8.6.14. DermLite
    • 8.6.14.1. Company overview
    • 8.6.14.2. Financial performance
    • 8.6.14.3. Product benchmarking
    • 8.6.14.4. Strategic initiatives

관련자료